Fm. Williams et al., ACCELERATED CUTANEOUS NODULOSIS DURING METHOTREXATE THERAPY IN A PATIENT WITH RHEUMATOID-ARTHRITIS, Journal of the American Academy of Dermatology, 39(2), 1998, pp. 359-362
Rheumatoid nodulosis is characterized by multiple small subcutaneous g
ranulomatous nodules typically located on the elbows in approximately
20% of patients with rheumatoid arthritis. Accelerated rheumatoid nodu
losis, especially involving the hands and feet, has recently been repo
rted in patients receiving methotrexate therapy for rheumatoid arthrit
is. We describe a woman with seropositive, erosive rheumatoid arthriti
s who, on two occasions, developed nonperiarticular subcutaneous nodul
es and new heart murmurs during methotrexate therapy, while her arthri
tis remained under good control, The nodules resolved after methotrexa
te was discontinued and recurred after methotrexate was reintroduced.
They again resolved after methotrexate was stopped and colchicine was
added. Her DNA oligotyping was positive for HLA-DRB10401, a genetic r
isk factor associated with accelerated rheumatoid nodulosis. Cutaneous
biopsy specimens revealed palisading granulomas and giant cells consi
stent with rheumatoid nodulosis.